Tags: Drug.

Muromonab-CD3 (trade name Orthoclone OKT3 marketed by Janssen-Cilag) is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants. It is a monoclonal antibody targeted at the CD3 receptor a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans.

Loading...

This page contains content from the copyrighted Wikipedia article "Muromonab-CD3"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.